Megachem Limited (SGX:5DS)
Singapore · Delayed Price · Currency is SGD 0.4850
0.00 (0.00%)
At close: Aug 14, 2026
Megachem Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 126.19 | 124.41 | 128.84 | 123.01 | 143.72 | 138.9 | |
Revenue Growth | -1.21% | -3.44% | 4.74% | -14.41% | 3.47% | 31.99% |
Cost of Revenue | 91.63 | 92.61 | 97.61 | 100.51 | 109.31 | 104.79 |
Gross Profit | 34.56 | 31.8 | 31.23 | 22.5 | 34.41 | 34.11 |
Selling, General & Admin | 25.54 | 24.19 | 28.6 | 27.4 | 23.37 | 23.88 |
Other Operating Expenses | 3.66 | 3.63 | 3.91 | 3.26 | 3.91 | 2.98 |
Operating Expenses | 29.2 | 27.82 | 32.51 | 30.65 | 27.28 | 26.86 |
Operating Income | 5.36 | 3.98 | -1.29 | -8.15 | 7.13 | 7.25 |
Interest Expense | -1.35 | -1.41 | -1.91 | -2.04 | -1.38 | -0.8 |
Interest & Investment Income | 0.18 | 0.18 | 0.12 | 0.09 | 0.05 | 0.09 |
Earnings From Equity Investments | 1.36 | 1.17 | 1.22 | 1.17 | 1.12 | 1.61 |
Currency Exchange Gain (Loss) | 0.02 | 0 | 0.04 | - | 0.03 | 0.01 |
Other Non Operating Income (Expenses) | 0.28 | 0.29 | 0.2 | 0.43 | 0.65 | 0.54 |
EBT Excluding Unusual Items | 5.86 | 4.21 | -1.6 | -8.51 | 7.6 | 8.7 |
Gain (Loss) on Sale of Investments | - | - | - | - | 0.15 | 0.2 |
Gain (Loss) on Sale of Assets | 0.07 | 0.04 | 0.62 | 0.01 | 0.08 | 0.01 |
Other Unusual Items | - | - | - | - | - | 0.27 |
Pretax Income | 7.18 | 4.27 | 8.69 | -5.34 | 7.83 | 9.19 |
Income Tax Expense | 0.39 | 0.36 | 0.78 | 0.46 | 1.76 | 1.2 |
Earnings From Continuing Operations | 6.79 | 3.91 | 7.91 | -5.8 | 6.07 | 7.99 |
Minority Interest in Earnings | -0.08 | -0.07 | -0.01 | -0.11 | -0.19 | -0.23 |
Net Income | 6.71 | 3.83 | 7.91 | -5.91 | 5.88 | 7.76 |
Net Income to Common | 6.71 | 3.83 | 7.91 | -5.91 | 5.88 | 7.76 |
Net Income Growth | -11.55% | -51.49% | - | - | -24.28% | 51.41% |
Shares Outstanding (Basic) | 133 | 133 | 133 | 133 | 133 | 133 |
Shares Outstanding (Diluted) | 133 | 133 | 133 | 133 | 133 | 133 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | 0.05 | 0.03 | 0.06 | -0.04 | 0.04 | 0.06 |
EPS (Diluted) | 0.05 | 0.03 | 0.06 | -0.04 | 0.04 | 0.06 |
EPS Growth | -11.50% | -51.49% | - | - | -24.28% | 51.41% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -7.85 | -8.59 | 8.31 | 14.64 | -4.64 | -11.29 |
Free Cash Flow Per Share | -0.06 | -0.06 | 0.06 | 0.11 | -0.04 | -0.09 |
Dividend Per Share | 0.010 | 0.010 | 0.010 | - | 0.020 | 0.020 |
Dividend Growth | 0% | 0% | - | - | 0% | 33.33% |
Gross Margin | 27.39% | 25.56% | 24.24% | 18.29% | 23.94% | 24.56% |
Operating Margin | 4.25% | 3.20% | -1.00% | -6.63% | 4.96% | 5.22% |
Profit Margin | 5.32% | 3.08% | 6.14% | -4.80% | 4.09% | 5.59% |
Free Cash Flow Margin | -6.22% | -6.90% | 6.45% | 11.90% | -3.23% | -8.13% |
EBITDA | 6.53 | 5.01 | -0.32 | -7.14 | 8.07 | 8.02 |
EBITDA Margin | 5.17% | 4.03% | -0.25% | -5.80% | 5.61% | 5.77% |
D&A For EBITDA | 1.16 | 1.03 | 0.97 | 1.01 | 0.94 | 0.77 |
EBIT | 5.36 | 3.98 | -1.29 | -8.15 | 7.13 | 7.25 |
EBIT Margin | 4.25% | 3.20% | -1.00% | -6.63% | 4.96% | 5.22% |
Effective Tax Rate | 5.44% | 8.40% | 8.96% | - | 22.52% | 13.02% |